Alcohol and Cancer: The 7 Cancer Types and the Evidence Behind the Link

In 2017, the American Society of Clinical Oncology surveyed US adults about known cancer risk factors. The results were striking: fewer than 50% were aware that alcohol consumption increases cancer risk — despite alcohol having been classified as a Group 1 carcinogen (definitively carcinogenic to humans) by the International Agency for Research on Cancer since 1988.

Alcohol contributes to approximately 4–6% of global cancer cases and a similar fraction of cancer deaths. The relationship is causal, not merely correlational — established through cohort studies, mechanistic research, and most recently by Mendelian randomization studies that isolate the causal effect of alcohol using genetic variants as natural experimental instruments.

Unlike tobacco, where public awareness of cancer risk is high, alcohol’s carcinogenicity remains poorly understood — partly because of industry messaging that has historically conflated moderate drinking’s cardiovascular associations with overall health benefit, and partly because the dose-response starts at lower consumption levels than many people expect. This article explains the mechanisms, the seven confirmed cancer types, and what the absence of a safe threshold means practically.

Why Alcohol Causes Cancer: The 4 Mechanisms

Alcohol (ethanol) is not itself the primary carcinogen. The carcinogenic cascade begins immediately after ethanol is consumed.

• Acetaldehyde — the primary carcinogen. Alcohol dehydrogenase (ADH) converts ethanol to acetaldehyde — a highly reactive genotoxic compound. Acetaldehyde forms covalent DNA adducts (N2-ethyl-dG) that interfere with replication and repair. Critically, oral bacteria also convert alcohol to acetaldehyde locally in the mouth and colon, sometimes at concentrations exceeding blood levels — delivering carcinogen directly to the mucosal surfaces with the highest cancer risk.
• Estrogen elevation. Alcohol impairs hepatic metabolism of estrogen, elevating circulating estradiol, estrone, and DHEAS. This pathway explains why the alcohol-breast cancer relationship is strongest in postmenopausal women who also use hormone replacement therapy — HRT already elevates estrogen, and alcohol amplifies it further.
• Folate depletion. Alcohol interferes with intestinal folate absorption, increases urinary folate excretion, and impairs folate-dependent one-carbon metabolism. Folate depletion leads to DNA hypomethylation and impaired nucleotide synthesis — mechanisms most relevant to colorectal cancer.
• Reactive oxygen species (ROS). At high ethanol concentrations, the liver activates CYP2E1 (the microsomal ethanol oxidizing system), generating ROS that cause oxidative DNA damage. CYP2E1 is induced with chronic alcohol use, amplifying this pathway in heavy drinkers.

The 7 Cancer Types Caused by Alcohol

1. Oral Cavity and Pharynx — Highest Relative Risk

Heavy drinkers (≥4 drinks/day) face approximately 5–7 times the cancer risk of non-drinkers. The mechanism is direct mucosal acetaldehyde exposure from blood-delivered alcohol and from bacteria-generated acetaldehyde in saliva. The tobacco-alcohol interaction here is multiplicative — a heavy smoker who also drinks heavily carries 20–100 times the risk of someone who does neither.

2. Larynx

The laryngeal mucosa is exposed to alcohol-saturated saliva and acid reflux containing acetaldehyde. Heavy drinker relative risk: approximately 3–5× non-drinker. Combined with tobacco, laryngeal cancer risk is dramatically elevated.

3. Esophagus (Squamous Cell Carcinoma)

The esophagus is bathed in alcohol and oral bacteria-derived acetaldehyde. Heavy drinkers face approximately 4–5 times the squamous cell carcinoma risk of non-drinkers. A critically important genetic amplifier applies to East Asian populations — ALDH2 deficiency (discussed in detail below) — which can multiply this risk by up to 90×.

4. Colorectal Cancer

Moderate drinkers (2–3 drinks/day) have approximately 20% higher colorectal cancer risk than non-drinkers; heavy drinkers have 50%+ elevated risk. The mechanism involves folate depletion and direct acetaldehyde exposure to colonic mucosa via bacteria-generated acetaldehyde in the large bowel. Low dietary folate amplifies this risk substantially.

5. Liver (Hepatocellular Carcinoma)

Alcohol causes HCC primarily through the intermediate of cirrhosis. Chronic heavy drinking causes fatty liver → alcoholic hepatitis → fibrosis → cirrhosis. Once cirrhosis is established, HCC develops at approximately 3–5% per year. Approximately 15–20% of chronic heavy drinkers develop cirrhosis. The combination of heavy alcohol with viral hepatitis B or C produces synergistic HCC risk far exceeding either exposure alone.

6. Breast Cancer — Most Important at Low Doses

A collaborative reanalysis of data from over 150,000 women (Hamajima et al.) established that each additional 10 grams of alcohol per day — approximately one standard drink — increases breast cancer relative risk by 7–10%. This dose-response begins at the lowest consumption levels studied. Both ER+ and ER- breast cancers are affected. Postmenopausal women using HRT who also drink have dramatically elevated breast cancer risk because both exposures elevate estrogen.

7. Stomach

Gastric cancer has a more modest but established causal relationship with alcohol through direct mucosal acetaldehyde irritation. Evidence is strongest for heavy consumption.

ALDH2 Deficiency: The Genetic Amplifier of Esophageal Cancer Risk

Approximately 35–45% of East Asian individuals (Chinese, Japanese, Korean) carry the ALDH2*2 allele, which reduces or eliminates the activity of ALDH2 — the enzyme that converts acetaldehyde to the non-toxic product acetate. ALDH2-deficient individuals cannot safely metabolize acetaldehyde.

The clinical manifestation is the “alcohol flush reaction”: flushing of the face and neck, nausea, rapid heartbeat, and headache after even small amounts of alcohol. This is not merely low alcohol tolerance — it is a biological signal that acetaldehyde is accumulating at toxic concentrations in the body.

The cancer consequences are severe:

• Esophageal SCC risk: 6–10× that of ALDH2-normal drinkers at equivalent consumption
• In heavy-drinking ALDH2 homozygous-deficient individuals: approximately 90× the esophageal SCC risk of non-drinking ALDH2-normal individuals (Brooks PJ, PLOS Med 2009)
• Elevated oral and pharyngeal cancer risk at equivalent alcohol doses

This is one of the most consequential gene-environment cancer risk interactions known in any common population — affecting tens of millions globally — yet it goes almost universally uncommunicated. Anyone who experiences alcohol flush reaction should understand that this symptom represents dangerous acetaldehyde accumulation and that continuing to drink carries extraordinary cancer risk.

Is There a Safe Level?

The World Cancer Research Fund (WCRF) 2018 Continuous Update Project concluded: “Even small amounts of alcoholic drinks increase the risk of some cancers.” No safe threshold for alcohol’s carcinogenicity has been established.

For cancer risk, alcohol does not show the J-curve sometimes described in cardiovascular disease literature. Cancer risk — particularly breast, colorectal, and upper aerodigestive tract cancers — increases linearly from zero consumption, with no protective effect at any dose. Mendelian randomization studies using genetic variants in alcohol metabolism (ADH1B, ALDH2) as instruments consistently support a causal relationship, independent of confounding lifestyle factors.

Cancer Risk by Cancer Type

Cancer Type	Relative Risk (Heavy Drinking)	Key Mechanism
Oral cavity / Pharynx	5–7×	Acetaldehyde (mucosal + salivary bacterial)
Larynx	3–5×	Acetaldehyde
Esophagus (SCC)	4–5× (up to 90× with ALDH2 deficiency)	Acetaldehyde; ALDH2 genetic amplification
Colorectal	1.5–2×	Folate depletion; colonic acetaldehyde
Liver (via cirrhosis)	3–4× (3–5%/yr once cirrhotic)	Cirrhosis; CYP2E1/ROS
Breast	+7–10% per drink/day (linear from zero)	Estrogen elevation; acetaldehyde
Stomach	~1.2–1.5×	Mucosal acetaldehyde

Does the Type of Alcohol Matter?

No. The carcinogen is ethanol and its metabolite acetaldehyde — present in beer, red wine, white wine, and spirits at equivalent ethanol doses. Red wine contains resveratrol, which has shown anti-cancer properties in laboratory studies, but at concentrations far below those used experimentally. Clinical trials of resveratrol supplementation have not demonstrated cancer prevention benefit in humans. There is no credible evidence that red wine’s composition offsets its alcohol-related cancer risk.

Alcohol + Tobacco: Multiplicative Risk

For head and neck cancers and esophageal squamous cell carcinoma, alcohol and tobacco produce synergistic — not additive — risk. The joint effect substantially exceeds the product of each individual risk. A heavy smoker who is also a heavy drinker carries a risk of oral, pharyngeal, and laryngeal cancer 20–100 times that of someone who does neither.

This interaction is mediated through converging mechanisms: both acetaldehyde and tobacco carcinogens attack the same mucosal cells, both impair DNA repair, and tobacco may enhance CYP2E1-mediated alcohol metabolism. The practical clinical implication: patients presenting with head and neck cancer should be counseled about both exposures simultaneously — cessation of both is critical for preventing second primary tumors.

Frequently Asked Questions

Does moderate drinking cause cancer?

Yes. Cancer risk increases linearly with alcohol consumption — there is no established threshold below which risk disappears. At one drink per day, breast cancer risk increases by approximately 7–10% compared to non-drinkers. The absolute risk from light drinking is modest, but it is not zero, and it applies to the most common alcohol-linked cancers affecting a large population.

Is red wine better than beer or spirits for cancer risk?

No. The carcinogen is ethanol and acetaldehyde — present in all alcoholic beverages at equivalent doses. Red wine’s resveratrol content does not meaningfully offset alcohol’s carcinogenic effect at usual consumption levels. No credible evidence supports the idea that any type of alcohol is safer than others at equivalent ethanol doses.

What is the alcohol flush reaction and why does it matter for cancer?

The alcohol flush reaction (“Asian flush”) is caused by ALDH2 deficiency — a genetic variant present in 35–45% of East Asians. ALDH2-deficient individuals cannot efficiently metabolize acetaldehyde after drinking. Flushing, nausea, and tachycardia are the symptoms of acetaldehyde accumulation. Continuing to drink despite these symptoms carries esophageal squamous cell carcinoma risk up to 90 times that of non-drinking ALDH2-normal individuals — making this one of the highest single-exposure cancer risks known in any common population.

Does stopping drinking reduce cancer risk?

Yes — cancer risk declines after cessation. For oral and pharyngeal cancers, risk falls measurably within 5–10 years. For liver cancer, risk reduction depends on whether cirrhosis has already developed — established cirrhosis maintains HCC risk even after alcohol cessation. For breast cancer, risk falls toward non-drinker levels over time. Cessation at any point is beneficial.

Should cancer survivors drink alcohol?

Evidence suggests alcohol affects outcomes for certain cancers. For breast cancer survivors, alcohol after diagnosis is associated with increased recurrence risk in some studies through continued estrogen elevation. ASCO and most major oncology societies recommend minimizing or avoiding alcohol during and after cancer treatment. Discuss this specifically with your oncologist, as some treatment agents also interact with alcohol pharmacologically.

How does folate interact with alcohol and colorectal cancer?

Alcohol depletes folate, and low folate amplifies colorectal cancer risk from alcohol. Adequate folate intake — from folate-rich foods (dark leafy greens, legumes) or supplementation — partially mitigates but does not eliminate alcohol-associated colorectal cancer risk. This is one reason why a folate-rich diet is recommended alongside minimizing alcohol, particularly for those at elevated colorectal cancer risk.

Does alcohol cancer risk apply equally to men and women?

Broadly yes, though the relevant cancers differ. Women face breast cancer risk at low consumption levels that has no male equivalent. Women also absorb more alcohol per unit consumed (lower total body water, lower gastric ADH activity), reaching higher peak blood alcohol at equivalent doses. For non-sex-specific cancers (oral, colorectal, liver, esophageal), risk is similar between sexes at equivalent alcohol exposure.

The Bottom Line

Alcohol’s role as a carcinogen is scientifically unambiguous — Group 1 evidence established over more than four decades. Yet it remains one of the most underappreciated cancer risk factors in public consciousness, obscured by cultural normalization, industry messaging, and selective emphasis on cardiovascular associations that do not extend to cancer.

The seven confirmed cancer types together represent a meaningful fraction of total cancer burden. The dose-response is linear without a safe floor. The ALDH2 deficiency story represents one of the most actionable genetic cancer risk signals that currently goes almost universally uncommunicated.

The scientific consensus — IARC, WCRF, ASCO — is consistent: for cancer prevention, the best choice is not to drink. If drinking does occur, less is less risky. The goal is not fear, but informed decision-making: replacing the impression that “a drink a day is good for you” with a more complete picture of what the evidence actually shows.